Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab, Bevacizumab, and Docetaxel in Stage IV Metastatic Breast Cancer
NCT00428922Phase 2Completed
- Sponsor
- Bhuvaneswari Ramaswamy
- Start
- Jun 2007
- Primary completion
- Nov 2012
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, bevacizumab, docetaxel in breast cancer, sponsored by Bhuvaneswari Ramaswamy. Started Jun 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00428922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428922.